Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK4425689A in Healthy Adult Participants
NCT07646353Phase 1Recruiting
- Sponsor
- GSK
- Start
- Jul 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of GSK4425689A in malaria (5 arms), sponsored by GSK. Primary endpoints: Adverse Events and Serious Adverse Events. Started Jul 2026; status: recruiting.
02
Drugs
GSK4425689A
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07646353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07646353.